Navigation Links
Lexogen Launches Quantitative RNA-Seq Service for Cost-efficient and Accurate Gene Expression Profiling
Date:3/1/2017

VIENNA, March 1, 2017 /PRNewswire/ -- Today Lexogen, a transcriptomics and next generation sequencing company, announces the start of its RNA-Seq service, which focuses on gene expression profiling using Lexogen's proprietary QuantSeq technology.

Lexogen's QuantSeq 3' mRNA-Seq Library Prep Kit has already been recognized as one of the fastest, most cost-efficient, and accurate methods for expression profiling using next generation sequencing. Analysis of QuantSeq data is based on counting of the transcripts and is therefore straightforward and robust. The proprietary QuantSeq protocol focuses on capture of the 3' end of mRNAs, which is very tolerant towards lower amount and integrity of the RNA input, therefore RNA extracted from clinical materials and FFPE-samples can also be submitted for accurate gene expression profiling.

The low read depth necessary for gene expression profiling by QuantSeq allows for a high degree of multiplexing and automation of the library preparation procedure accommodates projects with higher sample throughput. This makes QuantSeq the most preferable alternative to microarrays for gene expression profiling.

The all-inclusive service costs EUR 248 per sample, includes library preparation from submitted RNA, lane-mixing, sequencing and all required quality controls for processing 48 samples concurrently. Data analysis down to differential gene expression is included in the report, with further analyses available on request. Project management by the inventor of QuantSeq ensures support by experts in the field.

About Lexogen

Lexogen is a transcriptomics and next generation sequencing company, focusing on the development of technologies for complete transcriptome sequencing. Its portfolio includes innovative molecular biology kits, software, and services for RNA-Seq.

To learn more, visit www.lexogen.com and follow @lexogen.

Contact person at Lexogen:

Jakob Haglmüller
jakob.haglmueller@lexogen.com

Lexogen GmbH
Campus Vienna Biocenter 5
1030 Vienna
Austria

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lexogen-launches-quantitative-rna-seq-service-for-cost-efficient-and-accurate-gene-expression-profiling-300414989.html


'/>"/>
SOURCE Lexogen
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. Darrow Wealth Management Launches New Website
2. Guidepoint Global Launches Two Major Enhancements to its Client Research Portal
3. Elsevier Launches PracticeUpdate, a Free Information Portal for Physicians
4. Neogen launches rapid tests for ractopamine
5. Rockingham County Economic Development Launches New Website
6. BioHealth Innovation, Inc. Launches Program to Help Life Science Companies Navigate Federal Funding Application Process
7. Elsevier Launches Web-Based Pathway Studio and Adds New Molecular Data from Its Biology Journals to Boost Early Discovery Research
8. Dr. Richard Charmoy Launches Groundbreaking Cavity Prevention Program that Can Lower Tooth Decay Rates by 74%
9. CellHealth Institute Launches with Support from Influential Investors
10. Dr. Timothy Rauch of Albuquerque, New Mexico Launches a Groundbreaking Cavity Prevention Program
11. Neighborhood Smiles Launches a Groundbreaking Cavity Prevention Program for Their Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2020)... ... July 22, 2020 , ... Join experts from Reed Tech , ... Solutions, in a one hour live webinar on Thursday, August 13, 2020 ... for drugs and medical devices. Specifically, for medical devices, the NMPA has departments dealing ...
(Date:7/10/2020)... ... July 08, 2020 , ... Bode Technology, ... of laboratory operations through its COVID-19 testing service, Bode-CARES . Bode-CARES combines ... Bode-CARES provides a turnkey solution that includes a comprehensive collection and ...
(Date:7/7/2020)... ... July 06, 2020 , ... Bio-IT World has announced the ... Squibb, the University of Chicago, Massachusetts General Hospital, Mission: Cure, and the Pistoia ... program, highlighting outstanding examples of how technology innovations and strategic initiatives can be ...
(Date:6/28/2020)... SAN JOSE, Calif. (PRWEB) , ... June 25, ... ... the globe, researchers are racing to develop a vaccine or drug treatment. In ... company Recursion has publicly released the world’s largest imaging dataset portraying ...
Breaking Biology Technology:
(Date:7/10/2020)... ... July 08, 2020 , ... Overcoming Comparability Issues in Regenerative ... Webinar, Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/cellandgenetherapy ... effective way to complete one? Will the study comply with all FDA requirements? ...
(Date:7/2/2020)... (PRWEB) , ... July 01, 2020 , ... ... presented its phase 1a findings of Neihulizumab, a biologic for the treatment of ... June 2020. Led by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson ...
(Date:7/1/2020)... (PRWEB) , ... July 01, 2020 , ... ... building awareness and solutions for glioblastoma—the most common and aggressive adult brain cancer—announced ... Haile, JD, PhD. Senior Fellows are charged with supporting the organization’s initiatives and ...
Breaking Biology News(10 mins):